Home
Location: United States, California, South San Francisco
Employees: 11-50
Total raised: $327M
Founded date: 2018
Investors 1
| Date | Name | Website |
| - | HBM Partne... | hbmpartner... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 31.03.2022 | Series C | $100M | - |
| 02.03.2021 | Series A | $113.5M | - |
| 16.12.2020 | Series A | $113.5M | - |
Mentions in press and media 11
| Date | Title | Description | Source |
| 04.04.2022 | Neuron23 Closes $100M Series C Financing | Neuron23, a South San Francisco, CA-based biotechnology company, raised $100M in Series C funding. T... | finsmes.co... |
| 31.03.2022 | Neuron23 nabs $100M in SoftBank-led round | Neuron23 has raised a $100 million Series C led by SoftBank's Vision Fund 2. Based in the Bay Area, ... | pitchbook.... |
| 30.03.2022 | Neuron23 snags $100M and a new Parkinson's disease candidate | Neuron23 has picked a Parkinson’s disease clinical candidate, and, now, the small neurodegenerative-... | fiercebiot... |
| 30.03.2022 | Neuron23 Grabs $100M in Series C | SOUTH SAN FRANCISCO, CA, Neuron23, an early stage biotechnology company, has closed a $100 million... | vcnewsdail... |
| 02.03.2021 | Neuron23 closes USD 113.5 million series A and B financing | Martinsried-based Origenis GmbH has announced the formation and funding of South San Francisco biote... | bio-m.org/... |
| 17.12.2020 | Neuron23 emerges from stealth with $113.5M | Neuron23 has announced $33.5 million in Series A funding from WestLake Village BioPartners and Klein... | pitchbook.... |
| 16.12.2020 | Neuron23 Closes $113.5M Series A and B Financing | Neuron23, Inc., a South San Francisco, CA, and Munich, Germany-based early stage biotechnology compa... | finsmes.co... |
| 16.12.2020 | Neuron23 uncloaks with $113.5M to tackle CNS disorders throu... | Since October 2018, scientists at Neuron23 have worked quietly to find their place in the world of p... | fiercebiot... |
| 16.12.2020 | Neuron23 Snags $113.5M in Series A and B | SOUTH SAN FRANCISCO, CA, Neuron23 today announced its launch backed by a combined $113.5 million S... | vcnewsdail... |
| 16.12.2020 | Neuron23 uncloaks with $113.5M to tackle CNS disorders throu... | Since October 2018, scientists at Neuron23 have worked quietly to find their place in the world of p... | fiercebiot... |
Show more